Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roderick L Beijersbergen

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
Cell Reports|May 20, 2023
Multi-omics analysis reveals distinct non-reversion mechanisms of PARPi resistance in BRCA1- versus BRCA2-deficient mammary tumorsJinhyuk Bhin, Mariana Paes Dias, Ewa Gogola, et al.
Medrxiv : the Preprint Server for Health Sciences|March 3, 2023
Enhancer profiling identifies epigenetic markers of endocrine resistance and reveals therapeutic options for metastatic castration-resistant prostate cancer patientsTesa M Severson, Yanyun Zhu, Stefan Prekovic, et al.
Nature|July 22, 2021
EGFR activation limits the response of liver cancer to lenvatinibHaojie Jin, Yaoping Shi, Yuanyuan Lv, et al.
Cell|April 9, 2016
A Vulnerability of a Subset of Colon Cancers with Potential Clinical UtilityLoredana Vecchione, Valentina Gambino, Jonne Raaijmakers, et al.
Cell Reports. Medicine|July 3, 2025
Epigenetic profiling identifies markers of endocrine resistance and therapeutic options for metastatic castration-resistant prostate cancerTesa M Severson, Emma Minnee, Yanyun Zhu, et al.
Cell Reports|June 28, 2018
Neutrophils Kill Antibody-Opsonized Cancer Cells by TrogoptosisHanke L Matlung, Liane Babes, Xi Wen Zhao, et al.
Cancer Discovery|March 27, 2024
Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment StrategyMatheus Henrique Dias, Anoek Friskes, Siying Wang, et al.
Breast Cancer Research : BCR|June 3, 2014
VAV3 mediates resistance to breast cancer endocrine therapyHelena Aguilar, Ander Urruticoechea, Pasi Halonen, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
Cell Reports|May 20, 2023
Multi-omics analysis reveals distinct non-reversion mechanisms of PARPi resistance in BRCA1- versus BRCA2-deficient mammary tumorsJinhyuk Bhin, Mariana Paes Dias, Ewa Gogola, et al.
Medrxiv : the Preprint Server for Health Sciences|March 3, 2023
Enhancer profiling identifies epigenetic markers of endocrine resistance and reveals therapeutic options for metastatic castration-resistant prostate cancer patientsTesa M Severson, Yanyun Zhu, Stefan Prekovic, et al.
Nature|July 22, 2021
EGFR activation limits the response of liver cancer to lenvatinibHaojie Jin, Yaoping Shi, Yuanyuan Lv, et al.
Cell|April 9, 2016
A Vulnerability of a Subset of Colon Cancers with Potential Clinical UtilityLoredana Vecchione, Valentina Gambino, Jonne Raaijmakers, et al.
Cell Reports. Medicine|July 3, 2025
Epigenetic profiling identifies markers of endocrine resistance and therapeutic options for metastatic castration-resistant prostate cancerTesa M Severson, Emma Minnee, Yanyun Zhu, et al.
Cell Reports|June 28, 2018
Neutrophils Kill Antibody-Opsonized Cancer Cells by TrogoptosisHanke L Matlung, Liane Babes, Xi Wen Zhao, et al.
Cancer Discovery|March 27, 2024
Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment StrategyMatheus Henrique Dias, Anoek Friskes, Siying Wang, et al.
Breast Cancer Research : BCR|June 3, 2014
VAV3 mediates resistance to breast cancer endocrine therapyHelena Aguilar, Ander Urruticoechea, Pasi Halonen, et al.
Pageof 10